86% is the present pregnant women living with hiv antiretroviral therapy coverage for pmtct value in Ethiopia, reflecting an increase of 6% (7.5%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Ethiopia
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Ethiopia
PMTCT antiretroviral therapy coverage
More indicators for Ethiopia
Male unintentional poisoning
4.6
-0.2
(2019)
Female wasting in children
5.1%
-4.7%
(2019)
Female prevalence of HIV
0.3%
-0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar30
+intl dollar3
(2021)
Birth registration
2.7%
-3.9%
(2016)
Contraceptive modern method prevalence
35.6%
-4.9%
(2020)
Ethiopia PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 86% | +6% |
| 2021 | 80% | -13% |
| 2020 | 93% | +10% |
| 2019 | 83% | +5% |
| 2018 | 78% | +11% |
| 2017 | 67% | -3% |
| 2016 | 70% | -7% |
| 2015 | 77% | +6% |
| 2014 | 71% | +2% |
| 2013 | 69% | +10% |
| 2012 | 59% | +22% |
| 2011 | 37% | +13% |
| 2010 | 24% | -2% |
| 2009 | 26% | +2% |
| 2008 | 24% | +14% |
| 2007 | 10% | +1% |
| 2006 | 9% | +8% |
| 2005 | 1% | 0% |
| 2004 | 1% | 0% |
| 2003 | 1% | +1% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |